Granite Point Capital Management, L.P. Enanta Pharmaceuticals Inc Transaction History
Granite Point Capital Management, L.P.
- $0
- Q3 2023
Shares
2 transactions
Others Institutions Holding ENTA
# of Institutions
106Shares Held
21.5MCall Options Held
9.4KPut Options Held
3.3K-
Farallon Capital Management LLC San Francisco, CA2.1MShares$30 Million0.17% of portfolio
-
Morgan Stanley New York, NY2.05MShares$29.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.93MShares$27.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.84MShares$26.3 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.24MShares$17.7 Million0.29% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $297M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...